Delivery Order SPE2DB22D2005-SPE2DB25FJRE7
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,119.10 by the Defense Logistics Agency (DLA) on August 11, 2025, with an ultimate completion date of August 12, 2025. The delivery order is for M-M-R II vaccine vials to be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price, non-set-aside contract awarded through open competition, structured as a child contract under a larger vehicle. AmerisourceBergen Drug Corp, a...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials valued at $2,939.10. This competitively awarded, firm fixed-price contract is scheduled for completion by July 23, 2025, with performance to be conducted at the vendor's corporate office location in Conshohocken, PA. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 11, 2025, for M-M-R II vaccine vials with a ceiling value of $2,330.79. This firm fixed-price delivery order, which is not associated with any set-aside designation, is expected to be completed by August 12, 2025, and will be performed at the contractor's Conshohocken facility. The award represents a routine...
- The Defense Logistics Agency awarded a delivery order valued at $1,463.76 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 30, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is a child contract issued under...
- Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The $5,550.74 order has a completion date of February 13, 2024 and was awarded on February 12, 2024. This order is part of a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that enables Amerisourcebergen to deliver a range of pharmaceutical products and medical...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract valued at $7,685.70 by the Defense Logistics Agency (DLA) to provide M-M-R II vaccine vials. The order has a completion date of February 5, 2024 and was awarded on February 2, 2024. This delivery order is issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, valued at $7,053.84 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $4,685.90 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of M-M-R II vaccine vials. The contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $4,511.07 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This firm fixed price contract, issued on July 22, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company serves as a...
- The Defense Logistics Agency awarded a $6,225.48 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of July 23, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRE7Delivery Order
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $15,679.50 by the Defense Logistics Agency (DLA) for M-M-R II vaccine vials, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will be executed at the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The prime contract enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including vaccines, specialty medications, and medical commodities across multiple therapeutic domains. Through this comprehensive vehicle, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning itself as a critical vendor within the federal medical procurement landscape.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.7k | 8/11/25 |